Abstract P1-13-05: GAIN-2: Adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: results of the second safety interim analyses

Saved in:
Bibliographic Details
Main Authors: Möbus, Volker (Author) , Schneeweiss, Andreas (Author)
Format: Article (Journal) Conference Paper
Language:English
Published: February 2016
In: Cancer research
Year: 2016, Volume: 76, Issue: 4, Pages: P1-13-05
ISSN:1538-7445
DOI:10.1158/1538-7445.SABCS15-P1-13-05
Online Access:Resolving-System, Volltext: http://dx.doi.org/10.1158/1538-7445.SABCS15-P1-13-05
Resolving-System: https://cancerres.aacrjournals.org/content/76/4_Supplement/P1-13-05
Get full text
Author Notes:V Möbus, H-J Lück, H Forstbauer, G Wachsmann, A Ober, A Schneeweiss, B Christensen, E von Abel, E-M Grischke, H-G Höffkes, P Klare, K Yon-Dschun, S Schmatloch, J Furlanetto, N Burchardi, G von Minckwitz and S Loibl
Description
Item Description:Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX
Physical Description:Online Resource
ISSN:1538-7445
DOI:10.1158/1538-7445.SABCS15-P1-13-05